ISID is a 501(c)(3) nonprofit organization serving the global emerging diseases community. In 2021, ProMED published over 6,500 posts to its 10 different networks, all with comments written by subject matter experts at no cost to you. As we grapple with the true cost to information technology, increased demand for more data on posts and novel diseases, and support for our ever-growing internationally based staff members, we need your help.
Consider making a tax-deductible contribution to underwrite the day to day operations of ProMED, as well as our ambitious plans to modernize and grow our services.
If you are one of the 39% who spend more than an hour each week with ProMED
If you ever find ProMED important enough to share with your colleagues, staff, or students
If you are one of the 99% of readers who would miss ProMED